CN114681152A - Interventional artificial chordae implantation system - Google Patents
Interventional artificial chordae implantation system Download PDFInfo
- Publication number
- CN114681152A CN114681152A CN202011640133.7A CN202011640133A CN114681152A CN 114681152 A CN114681152 A CN 114681152A CN 202011640133 A CN202011640133 A CN 202011640133A CN 114681152 A CN114681152 A CN 114681152A
- Authority
- CN
- China
- Prior art keywords
- anchor
- artificial chordae
- puncture needle
- interventional
- far
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
- A61F2/2457—Chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/246—Devices for obstructing a leak through a native valve in a closed condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Description
技术领域technical field
本发明涉及医疗器械技术领域,尤其涉及一种介入式人工腱索植入系统。The invention relates to the technical field of medical devices, in particular to an interventional artificial tendon chord implantation system.
背景技术Background technique
二尖瓣为左心房和左心室之间的单向阀门,可以保证血液从左心房流向左心室。如图1所示,正常健康的二尖瓣1可以控制血液从左心房2流到左心室3,同时避免血液从左心室3流到左心房2。二尖瓣1包括一对瓣叶,称为前叶1a及后叶1b。前叶1a及后叶1b分别通过各自的腱索4固定于左心室3的乳头肌上。正常情况下,左心室3收缩时,前叶1a和后叶1b的边缘完全对合,避免血液从左心室3流到左心房2。如图2所示,当二尖瓣1的腱索4部分断裂,将导致二尖瓣1的前叶1a和后叶1b对合不良,由此,当左心室3收缩时,二尖瓣1不能完全关闭,导致血液从左心室3返流至左心房2,从而引起一系列的病理生理改变,称为“二尖瓣返流”。The mitral valve is a one-way valve between the left atrium and the left ventricle that allows blood to flow from the left atrium to the left ventricle. As shown in FIG. 1 , a normal healthy
目前可以采用外科手术植入缝线作为人工腱索的方式治疗腱索病变,但是需要采用侵入性开胸技术,并实行全麻、中度低温体外循环作为辅助支持,手术过程复杂、成本高,而且病人受创伤程度高、并发症风险高、恢复过程痛苦。At present, chordae tendineopathy can be treated by surgically implanting sutures as artificial chordae tendineae, but it requires invasive thoracotomy technique, general anesthesia and moderate hypothermic cardiopulmonary bypass as auxiliary support. The operation process is complicated and the cost is high. Moreover, patients suffer from high levels of trauma, high risk of complications, and painful recovery.
另一种治疗方式是通过微创方式植入缝线作为人工腱索。例如,通过经心尖的路径,在左心房侧二尖瓣瓣叶的表面上植入一根缝线,作为人工腱索维持心室壁对瓣叶的拉力。现有的一种经心尖人工腱索植入器械,其远端包括可相对开合的近端夹头与远端夹头以夹持瓣叶,远端夹头内预设有套筒,套筒固定连接缝线,近端夹头内设有穿刺针,如图3所示,穿刺针5穿过瓣叶6后穿入套筒7内部并与套筒7内部的锁止结构相连,通过后撤穿刺针5以带动套筒7及与套筒7相连的缝线8穿过瓣叶6以实现人工腱索植入。然而,这种现有的人工腱索植入系统一方面需要在远端夹头内设置套筒,穿刺针穿刺瓣叶之后连接套筒,才能实现穿刺针与缝线的连接,结构较为复杂;另一方面,需要更换额外的固定系统将缝线固定至心尖、心室壁或乳头肌上,手术过程较复杂,耗时较长。Another treatment option is to implant sutures as artificial chordae tendineae in a minimally invasive way. For example, through a transapical approach, a suture is implanted on the surface of the mitral valve leaflet on the left atrial side as an artificial chordae tendineae to maintain the pull of the ventricular wall on the valve leaflet. An existing transapical artificial chordae implantation device includes a proximal end collet and a distal end collet that can be opened and closed relative to each other to clamp the valve leaflets, the distal end collet is preset with a sleeve, and the sleeve The barrel is fixed with sutures, and a puncture needle is arranged in the proximal end collet. As shown in Figure 3, the
发明内容SUMMARY OF THE INVENTION
为解决上述技术问题,本发明提供一种介入式人工腱索植入系统,结构简单,操作简便,有利于简化手术过程及节省手术时间。In order to solve the above technical problems, the present invention provides an interventional artificial chordae tendineae implantation system, which has a simple structure and simple operation, which is beneficial to simplify the operation process and save the operation time.
本发明提供的人工腱索植入系统,包括人工腱索及人工腱索植入装置。所述人工腱索植入装置包括鞘管、夹持组件、穿刺针及锚定组件。所述夹持组件包括相对开合的近端夹头和远端夹头,其中,所述近端夹头固定连接于所述鞘管的远端,所述远端夹头上设有沿轴向贯通且穿通所述远端夹头侧壁的通道。所述穿刺针活动穿设于所述鞘管及所述近端夹头内并可经由所述通道穿入所述远端夹头。所述锚定组件包括锚钉及与所述锚钉可拆卸连接的第一推送件,所述第一推送件活动穿设于所述穿刺针内并将所述锚钉推出所述穿刺针的远端。所述人工腱索活动穿设于所述第一推送件内,且其远端连接所述锚钉。The artificial tendon chord implantation system provided by the present invention includes an artificial tendon chord and an artificial tendon chord implantation device. The artificial chordae tendineae implantation device includes a sheath tube, a clamping component, a puncture needle and an anchoring component. The clamping assembly includes a proximal collet and a distal collet that are relatively open and close, wherein the proximal collet is fixedly connected to the distal end of the sheath, and the distal collet is provided with an axial A channel extends through and through the sidewall of the distal collet. The puncture needle is movably passed through the sheath tube and the proximal collet and can penetrate into the distal collet through the channel. The anchor assembly includes an anchor and a first pusher detachably connected to the anchor, the first pusher is movably penetrated into the puncture needle and pushes the anchor out of the puncture needle. remote. The artificial tendon is movably passed through the first pushing member, and the distal end thereof is connected to the anchor.
本发明提供的介入式人工腱索植入系统,在穿刺针内活动穿设锚定组件,在远端夹头上设置沿轴向贯通且穿通远端夹头侧壁的通道供穿刺针活动穿入,通过其中的夹持组件夹持瓣叶,通过穿刺针及其内的锚定组件穿刺瓣叶,随后通过第一推送件将锚钉推出穿刺针及远端夹头直至锚钉锚入心室壁或乳头肌,使得与穿刺针连接的人工腱索借助锚钉锚定于心室壁或乳头肌。与现有技术相比,省略了在远端夹头内设置套筒,穿刺针仅需穿刺瓣叶,无需穿刺针和套筒配合并形成连接的操作,简化了器械结构及操作过程;此外,使用同一套器械即可完成瓣叶穿刺和锚钉固定,操作步骤得以减少,有利于简化手术过程及节省手术时间。In the interventional artificial chordae tendineae implantation system provided by the present invention, an anchoring component is movably passed through the puncture needle, and a channel penetrating axially and penetrating the side wall of the distal end collet is arranged on the distal collet for the puncture needle to move through. The valve leaflet is clamped by the clamping assembly therein, the valve leaflet is punctured by the puncture needle and the anchoring assembly in it, and then the anchor is pushed out of the puncture needle and the distal collet through the first pusher until the anchor is anchored into the ventricle wall or papillary muscle so that the artificial chordae tendineae connected to the needle are anchored to the ventricular wall or papillary muscle by means of anchors. Compared with the prior art, the arrangement of the sleeve in the distal collet is omitted, the puncture needle only needs to puncture the valve leaflet, and the operation of cooperating and forming the connection between the puncture needle and the sleeve is not required, which simplifies the device structure and operation process; in addition, The valve leaflet puncture and anchor fixation can be completed by using the same set of instruments, and the operation steps are reduced, which is beneficial to simplify the operation process and save the operation time.
附图说明Description of drawings
为了更清楚地说明本发明实施例的技术方案,下面将对实施方式中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图是本发明一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to explain the technical solutions of the embodiments of the present invention more clearly, the following will briefly introduce the accompanying drawings that need to be used in the implementation manner. Obviously, the accompanying drawings in the following description are some embodiments of the present invention. As far as technical personnel are concerned, other drawings can also be obtained based on these drawings without any creative effort.
图1是二尖瓣处于正常状态时的示意图。Figure 1 is a schematic view of the mitral valve in its normal state.
图2是二尖瓣处于关闭不全状态时的示意图。Figure 2 is a schematic view of the mitral valve in a state of insufficiency.
图3是现有技术中的人工腱索植入器械的穿刺过程的示意图。FIG. 3 is a schematic diagram of the puncturing process of the artificial chordae tendineae implantation device in the prior art.
图4是本发明第一实施例提供的介入式人工腱索植入系统的局部立体结构示意图。FIG. 4 is a schematic partial three-dimensional structure diagram of the interventional artificial chordae tendineae implantation system provided by the first embodiment of the present invention.
图5是图4所示的介入式人工腱索植入系统在夹持组件打开时的立体结构示意图。FIG. 5 is a schematic three-dimensional structural diagram of the interventional artificial chord implantation system shown in FIG. 4 when the clamping assembly is opened.
图6是图4所示的介入式人工腱索植入系统的局部轴向剖视图。FIG. 6 is a partial axial cross-sectional view of the interventional artificial chord implantation system shown in FIG. 4 .
图7是图6所示的VII部分的放大示意图。FIG. 7 is an enlarged schematic view of part VII shown in FIG. 6 .
图8是图4所示的远端夹头连接驱动杆的立体结构示意图。FIG. 8 is a schematic three-dimensional structural diagram of the distal collet connecting drive rod shown in FIG. 4 .
图9是图8所示的远端夹头连接驱动杆的端面示意图。FIG. 9 is a schematic view of the end of the distal collet connecting the drive rod shown in FIG. 8 .
图10是图6中人工腱索及锚定组件的立体结构示意图。FIG. 10 is a schematic three-dimensional structural diagram of the artificial chordae tendineae and the anchoring assembly in FIG. 6 .
图11是图10所示的人工腱索及锚定组件的立体分解结构示意图。FIG. 11 is a schematic exploded perspective view of the artificial chordae tendineae and the anchoring assembly shown in FIG. 10 .
图12至图23是介入式人工腱索植入系统的使用过程示意图;12 to 23 are schematic diagrams of the use process of the interventional artificial chord implantation system;
其中,图12示意出了夹持组件夹持瓣叶;Wherein, Figure 12 illustrates the clamping assembly clamping the leaflets;
图13为图12中XIII部位的放大示意图;Fig. 13 is the enlarged schematic diagram of XIII part in Fig. 12;
图14示意出了穿刺针及其内的锚定组件穿刺瓣叶;Figure 14 illustrates the puncture needle and the anchoring assembly within the puncture leaflet;
图15为图14的剖视示意图;Figure 15 is a schematic cross-sectional view of Figure 14;
图16示意出了锚定组件穿出穿刺针及远端夹头;Figure 16 illustrates the anchoring assembly passing through the needle and distal collet;
图17为图16的剖视示意图;Figure 17 is a schematic cross-sectional view of Figure 16;
图18示意出了锚定组件中的第一推送件与锚钉分离;Figure 18 illustrates the separation of the first pusher in the anchor assembly from the anchor;
图19为图18的剖视示意图;Figure 19 is a schematic cross-sectional view of Figure 18;
图20示意出了锚钉锚入乳头肌;Figure 20 illustrates the anchoring of the anchor into the papillary muscle;
图21示意出了除锚钉与人工腱索外,介入式人工腱索植入系统撤出体外;Figure 21 shows that the interventional artificial chord implantation system is withdrawn from the body except for the anchor and the artificial chord;
图22示意出了垫片被推送至瓣叶;Figure 22 illustrates the shim being pushed to the leaflets;
图23示意出了锁结装置将人工腱索锁结固定于垫片远离瓣叶的一侧。Figure 23 illustrates the locking device securing the artificial chordae to the side of the spacer away from the leaflets.
图24是本发明第二实施例提供的介入式人工腱索植入系统的锚定组件及穿刺针的远端部分的轴向剖视图。24 is an axial cross-sectional view of the anchoring assembly and the distal end portion of the puncture needle of the interventional artificial chordae tendineae implantation system provided by the second embodiment of the present invention.
图25是图24中的锚钉连接人工腱索且锚钉的锚片处于合拢状态时的立体结构示意图。FIG. 25 is a schematic three-dimensional structural diagram of the anchor in FIG. 24 when the artificial chordae tendineae are connected and the anchor pieces of the anchor are in a closed state.
图26是图25所示的锚钉连接人工腱索且锚钉的锚片处于展开状态时的立体结构示意图。FIG. 26 is a schematic three-dimensional structural diagram of the anchor shown in FIG. 25 when the artificial chordae is connected and the anchor piece of the anchor is in a deployed state.
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有付出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
此外,以下各实施例的说明是参考附加的图示,用以例示本发明可用以实施的特定实施例。本发明中所提到的方向用语,例如,“上”、“下”、“前”、“后”、“左”、“右”、“内”、“外”、“侧面”等,仅是参考附加图示的方向,因此,使用的方向用语是为了更好、更清楚地说明及理解本发明,而不是指示或暗示所指的系统或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。Furthermore, the following descriptions of the various embodiments refer to the accompanying drawings to illustrate specific embodiments in which the invention may be practiced. Directional terms mentioned in the present invention, such as "up", "down", "front", "rear", "left", "right", "inside", "outside", "side", etc., only Reference is made to the directions of the accompanying drawings, therefore, the directional terms used are for better and clearer description and understanding of the present invention, rather than indicating or implying that the system or element referred to must have a particular orientation, be configured in a particular orientation and operation, and therefore should not be construed as limiting the present invention.
需要说明的是,为了更加清楚地描述介入式缝线植入系统及介入式腱索植入系统的结构,本发明在说明书中所述的限定术语“近端”及“远端”为介入医疗领域惯用术语。具体而言,“远端”表示手术操作过程中远离操作人员的一端,“近端”表示手术操作过程中靠近操作人员的一端。将柱体、管体等一类物体的旋转中心轴的方向定义为轴向。周向为围绕柱体、管体等一类物体的轴线的方向(垂直于轴线,同时垂直于截面半径)。径向就是沿直径或半径的直线方向。除非另有定义,本发明所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本发明在说明书中所使用的惯用术语只是为了描述具体实施例的目的,并不能理解为对本发明的限制。It should be noted that, in order to more clearly describe the structure of the interventional suture implantation system and the interventional chord implantation system, the defined terms “proximal end” and “distal end” described in the specification of the present invention refer to interventional medical Domain terminology. Specifically, the "distal end" refers to the end away from the operator during the surgical operation, and the "proximal end" refers to the end close to the operator during the surgical operation. The direction of the central axis of rotation of objects such as cylinders and tubes is defined as the axial direction. The circumferential direction is the direction (perpendicular to the axis and perpendicular to the radius of the section) around the axis of objects such as cylinders and tubes. Radial is the direction of a straight line along a diameter or radius. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The conventional terms used in the specification of the present invention are only for the purpose of describing specific embodiments, and should not be construed as limiting the present invention.
请一并参阅图4至图7,本发明第一实施例提供的介入式人工腱索植入系统9,包括人工腱索10及人工腱索植入装置20,其中,人工腱索植入装置20包括鞘管21、夹持组件23、穿刺针25及锚定组件27。Please refer to FIG. 4 to FIG. 7 together. The interventional artificial
具体的,如图4及图5所示,夹持组件23包括可相对开合的近端夹头232和远端夹头234,近端夹头232固定连接于鞘管21的远端;如图6及图7所示,穿刺针25活动穿设于鞘管21及近端夹头232内,远端夹头234上设有沿轴向贯通且穿通远端夹头234侧壁的通道238,以供穿刺针25活动穿入;如图6及图7所示,锚定组件27活动穿设于穿刺针25内,其包括锚钉271、及与锚钉271可拆卸连接的第一推送件273,第一推送件273用于将锚钉271推出穿刺针25的远端;如图6及图7所示,人工腱索10活动穿设于第一推送件273内,且其远端连接锚钉271。Specifically, as shown in FIGS. 4 and 5 , the clamping
进一步的,如图5及图6所示,夹持组件23还包括至少一根驱动杆236,驱动杆236轴向活动穿设于鞘管21与近端夹头232内,且驱动杆236的远端固定连接远端夹头234,驱动杆236沿轴向移动以带动远端夹头234相对近端夹头232开合,进而夹持瓣叶。需要说明的是,人工腱索植入装置20还包括手柄(图中未示),鞘管21、驱动杆236、穿刺针25以及第一推送件273的近端均延伸至人体外并且与所述手柄连接,所述手柄用于控制鞘管21、驱动杆236、穿刺针25以及第一推送件273等,此处不对手柄的具体结构做赘述。Further, as shown in FIG. 5 and FIG. 6 , the clamping
作为植入物的人工腱索10具有柔性,即,人工腱索10在轴向上没有拉伸的情况下,可以任意弯曲;为保证植入安全性,人工腱索10可以由生物相容性良好的高分子材料制成,优选为PTFE、e-PTFE、PET等高分子材料。本实施例中,人工腱索10采用e-PTFE缝线。The
请一并参阅图6及图7,近端夹头232及远端夹头234均大致呈圆柱状。近端夹头232及远端夹头234均可以由生物相容性良好的聚合物材料或者金属材料制成,其中,所述聚合物材料包括但不限于PP、PE、PET、PTFE、Pebax、PC中的一种或者几种,所述金属材料包括但不限于不锈钢、镍钛等。近端夹头232与远端夹头234的材料可以相同或者不同。Please refer to FIG. 6 and FIG. 7 together, the
如图6及图7所示,近端夹头232可通过螺纹连接、卡合连接、粘接或者焊接等任一方式固定连接于鞘管21的远端。近端夹头232开设有沿轴向贯通其两端的中空内腔,所述中空内腔与鞘管21的内腔连通;此外,近端夹头232还开设有驱动杆腔,所述驱动杆腔位于所述中空内腔的一侧且沿轴向贯通近端夹头232的两端,所述驱动杆腔用于活动穿设驱动杆236,所述驱动杆腔的形状与驱动杆236的形状匹配。As shown in FIG. 6 and FIG. 7 , the
请一并参阅图6至图9,远端夹头234固定连接于驱动杆236的远端,驱动杆236用于带动远端夹头234相对近端夹头232开合以夹持瓣叶。Please refer to FIGS. 6 to 9 together, the
其中,近端夹头232与远端夹头234夹持瓣叶时,近端夹头232的远端面及远端夹头234的近端面即为两个夹持面。可选的,为更有效地夹持瓣叶,所述两个夹持面中的至少一个设有防滑结构,所述防滑结构可以为凹凸结构、波纹结构等,优选波纹结构。进一步优选的,本实施例中,所述两个夹持面(即近端夹头232的远端面及远端夹头234的近端面)均倾斜于夹持组件23的轴向设置,以方便瓣叶进入并增加夹持面的面积。Wherein, when the
如图6至图9所示,所述通道238包括围绕远端夹头234的轴线且轴向贯通的第一槽体2381以及连通于第一槽体2381并穿通远端夹头234的侧壁的第二槽体2382。具体的,如图9所示,第一槽体2381的垂直于远端夹头234轴向的横截面形状为弧形,所述弧形对应的圆心角大于或者等于180度,且第一槽体2381的直径大于或者等于穿刺针25的直径,以便于穿刺针25穿刺瓣叶后能够无阻碍的进入通道238。本实施例中,第一槽体2381的弧形横截面对应的圆心角等于180度。如图9所示,第二槽体2382的垂直于远端夹头234轴向的横截面形状概为矩形,所述矩形的宽度等于或者小于穿刺针25的直径并大于人工腱索10的直径,以便于人工腱索10穿过瓣叶并且通过锚钉271锚定于心室壁或乳头肌后可自由地从远端夹头234中脱出,使得穿过瓣叶的人工腱索10不受远端夹头234的牵制,从而使远端夹头234可随整个器械顺畅撤出到体外。本实施例中,第二槽体2382的矩形横截面的宽度等于穿刺针25的直径。As shown in FIG. 6 to FIG. 9 , the
请一并参阅图6及图7,至少一根驱动杆236的远端经鞘管21的内腔及近端夹头232的驱动杆腔穿出近端夹头232的远端,然后与远端夹头234连接,以用于带动远端夹头234相对近端夹头232开合。其中,驱动杆236优选由镍钛管或者镍钛丝制成,且其截面形状可以是圆形、矩形或者三角形等任意形状。可以理解的是,矩形或者三角形截面的驱动杆236在鞘管21的内腔及近端夹头232的驱动杆腔中沿轴向移动时不会发生转动,从而可避免驱动杆236带动远端夹头234相对近端夹头232开合过程中远端夹头234相对近端夹头232旋转。Please refer to FIG. 6 and FIG. 7 together, the distal end of at least one driving
在其他实施例,近端夹头232与远端夹头234之间可以设置导向杆,所述导向杆与驱动杆236平行,其中,所述导向杆的一端固定连接近端夹头232与远端夹头234中的一个,所述导向杆的另一端滑动连接近端夹头232与远端夹头234中的另一个,由此,驱动杆236带动远端夹头234相对近端夹头232开合时,所述导向杆可以起到导向的作用,且与驱动杆236配合,共同起到止转的作用,同样可以避免远端夹头234相对近端夹头232旋转。In other embodiments, a guide rod may be provided between the
请再次参阅图6及图7,穿刺针25为中空的管体,具有一定刚性和柔顺性,优选镍钛材料制成。穿刺针25的内腔用于活动穿设锚定组件27,穿刺针25的远端为尖锐端以便于穿刺由近端夹头232和远端夹头234夹持的瓣叶。Please refer to FIG. 6 and FIG. 7 again, the
穿刺针25穿过瓣叶并穿入远端夹头234的通道238后,锚定组件27可随着穿刺针25一并穿过瓣叶,然后第一推送件273可将锚钉271推出穿刺针25及远端夹头234直至锚钉271锚入心室壁或乳头肌,从而使得连接于锚钉271的人工腱索10锚定于心室壁或乳头肌。After the
具体的,请一并参阅图6、图10及图11,本实施例中,锚钉271为螺旋式锚钉,其包括钉座2713及连接于钉座2713的远端的螺旋钉体2715,人工腱索10的远端固定连接于钉座2713,螺旋钉体2715转动以锚入心室壁或乳头肌,从而将人工腱索10锚定于心室壁或乳头肌。钉座2713、螺旋钉体2715选用生物相容性良好的金属材料制成,例如不锈钢。Specifically, please refer to FIG. 6 , FIG. 10 and FIG. 11 together. In this embodiment, the
人工腱索10的数量为至少一根,并通过粘接、打结或者压接等任一方式固定连接钉座2713。如图6所示,本实施例中,人工腱索10的数量设置为一根,钉座2713沿轴向设有通孔,人工腱索10的远端穿过钉座2713的通孔并打结固定,使得线结不能通过钉座2713的通孔,从而与钉座2713形成固定连接。需要说明的是,人工腱索10的近端穿出第一推送件273的近端并延伸至人体外,以便于后续进行锁结固定及裁剪。The number of the
如图10及图11所示,第一推送件273为中空的管体,其具有一定刚性和柔顺性,第一推送件273可以由生物相容性良好的金属材料或者高分子材料制成,例如镍钛或者Peek。本实施例中,第一推送件273用于将锚钉271推出穿刺针25的远端,并用于驱动锚钉271旋转以使螺旋钉体2715旋转锚入心室壁或乳头肌。具体的,本实施例中,钉座2713的近端上设有第一连接部2711,第一推送件273的远端对应第一连接部2711设有第二连接部2732,第一连接部2711与第二连接部2732可拆卸连接,使锚钉271与第一推送件273可拆卸连接,进而使第一推送件273沿轴向向远端的移动可将锚钉271推出穿刺针25的远端、及第一推送件273的转动能够带动锚钉271旋转。更具体的,本实施例中,第一连接部2711与第二连接部2732分别设有形状互补、互相拼接的凹凸结构,例如,所述凹凸结构为S形,第一连接部2711与第二连接部2732相互搭接,从而实现锚钉271与第一推送件273的可拆卸连接。需要说明的是,第一连接部2711与第二连接部2732连接时,其内部连通且与第一推送件273的内腔及钉座2713的通孔贯通,以便于人工腱索10穿过。As shown in FIG. 10 and FIG. 11 , the first pushing
进一步的,如图10及图11所示,本实施例中,锚定组件27还包括限位件275,用于限制第一连接部2711与第二连接部2732的脱离。具体的,限位件275为中空的管体,具有一定刚性和柔顺性,限位件275可以由生物相容性良好的金属材料或者高分子材料制成,例如镍钛或者Peek。其中,第一推送件273与限位件275的材料可以相同或者不相同。本实例例中,第一推送件273与限位件275均为镍钛管。Further, as shown in FIGS. 10 and 11 , in this embodiment, the anchoring
如图10所示,在一种实施方式中,限位件275轴向活动穿设于第一推送件273内,限位件275沿轴向向远端移动至其远端插入第一连接部2711与第二连接部2732的内部,能够限制第一连接部2711与第二连接部2732的脱离,使得第一推送件273连接于锚钉271,以实现第一推送件273带动锚钉271的移动及转动;限位件275沿轴向向近端移动至其远端从第一连接部2711与第二连接部2732的内部抽离,能够解除其对第一连接部2711与第二连接部2732的限制,使得第一推送件273可与锚钉271分离,以实现锚钉271的释放。As shown in FIG. 10 , in one embodiment, the limiting
在另一种实施方式中,限位件275可以活动套设于第一推送件273外,限位件275沿轴向向远端移动至其远端包绕第一连接部2711与第二连接部2732的外部,能够限制第一连接部2711与第二连接部2732的脱离,使得第一推送件273连接于锚钉271,以实现第一推送件273带动锚钉271的移动及转动;限位件275沿轴向向近端移动至其远端暴露第一连接部2711与第二连接部2732的外部,能够解除其对第一连接部2711与第二连接部2732的限制,使得第一推送件273可与锚钉271分离,以实现锚钉271的释放。可以理解的是,相比于将限位件275穿设于第一推送件273内,将限位件275套设于第一推送件273外会增加穿刺针25的直径,因此,优选限位件275穿设于第一推送件273内。In another embodiment, the limiting
本实施例中,介入式人工腱索植入系统9还包括垫片、第二推送件及锁结装置(未图示)。在人工腱索10锚定于心室壁或乳头肌上之后,所述垫片及第二推送件套设于人工腱索10上,且所述第二推送件的远端抵接所述垫片以用于推顶所述垫片沿人工腱索10移动至贴合于瓣叶,所述锁结装置用于将人工腱索10远离锚钉271的一端定位至所述垫片远离瓣叶的一侧上,从而完成人工腱索10的锁结固定。In this embodiment, the interventional artificial
其中,所述第二推送件为中空的管体,具有一定刚性和柔顺性,所述第二推送件可以由生物相容性良好的金属材料或者高分子材料制成,例如镍钛或者Peek;所述垫片为具有一定厚度和尺寸的片状结构,其材质可选择生物相容性良好的聚酯布等材料,所述垫片上设有供人工腱索10活动穿过的通孔,优选的,所述通孔的直径小于穿刺针25的直径,由此,所述垫片贴合于瓣叶后能够覆盖瓣叶上的穿刺口,弥补瓣叶损伤,减小漏血风险,并且可以分散人工腱索10对瓣叶的作用力,有利于降低人工腱索10撕裂瓣叶的风险。Wherein, the second pushing member is a hollow tube body with certain rigidity and flexibility, and the second pushing member can be made of a metal material or polymer material with good biocompatibility, such as nickel titanium or Peek; The gasket is a sheet-like structure with a certain thickness and size, and its material can be selected from materials such as polyester cloth with good biocompatibility. Preferably, the diameter of the through hole is smaller than the diameter of the
此外,还需要说明的是,介入式人工腱索植入系统9还包括导引鞘(未图示),鞘管21轴向活动穿设于所述导引鞘中,且所述导引鞘的远端设有至少一个可调弯段或者预塑形段,可以使所述导引鞘的远端发生弯曲,以使所述导引鞘沿导丝通过人体复杂的管腔结构,鞘管21及其远端的夹持组件23可以通过所述导引鞘的内腔到达预定治疗位点附近。In addition, it should be noted that the interventional artificial chorda tendineae
请一并参阅图12至图23,以下以经导管二尖瓣腱索修复术为例,说明本发明提供的介入式人工腱索植入系统9的使用过程。其中,手术的介入路径为:经股静脉-下腔静脉-右心房-房间隔-左心房-二尖瓣。Please refer to FIG. 12 to FIG. 23 together. The following uses transcatheter mitral valve chordae tendineae repair as an example to describe the use process of the interventional artificial chordae
第一步:经股静脉穿刺,送入导丝直至右心房,再通过房间隔穿刺针等器械穿刺房间隔的卵圆窝位置,将导丝由右心房送至左心房,到达二尖瓣附近,从而建立从体外到体内的通道。The first step: puncture through the femoral vein, send the guide wire to the right atrium, and then puncture the fossa ovalis of the atrial septum with instruments such as an atrial septal puncture needle, and send the guide wire from the right atrium to the left atrium to reach the vicinity of the mitral valve , thereby establishing a pathway from in vitro to in vivo.
第二步:沿导丝将所述导引鞘输送至二尖瓣附近,撤除导丝保留所示导引鞘,再通过所述导引鞘的内腔,将人工腱索植入装置20的鞘管21的远端部分及夹持组件23输送至二尖瓣附近。Step 2: The guide sheath is transported along the guide wire to the vicinity of the mitral valve, the guide wire is removed to retain the shown guide sheath, and the artificial chordae tendineae are implanted into the inner cavity of the guide sheath The distal portion of the
第三步:控制驱动杆236向远端移动以带动远端夹头234相对近端夹头232打开,调整鞘管21远端部分的位置和弯曲角度,直至瓣叶6进入近端夹头232与远端夹头234之间的间隙,然后控制驱动杆236向近端移动以带动远端夹头234相对近端夹头232闭合,使瓣叶6被夹持于近端夹头232与远端夹头234之间(如图12及图13所示)。Step 3: Control the
第四步:同时推送穿刺针25和锚定组件27,使锚定组件27的远端随穿刺针25一并穿过由近端夹头232与远端夹头234夹持的瓣叶6(如图14及图15所示)。The fourth step: push the
第五步:同步推送锚定组件27中的第一推送件273和限位件275,使锚定组件27伸出穿刺针25及远端夹头234,直至抵达乳头肌或者心室壁附近(如图16及图17所示)。Step 5: Push the
第六步;通过旋转第一推送件273带动锚钉271转动,使螺旋钉体2715锚入乳头肌或者心室壁,进而使人工腱索10锚定于乳头肌或者心室壁上,然后向近端移动限位件275,使得第一推送件273与锚钉271分离,实现锚钉271的释放(如图18及图19所示);此时,近端夹头232及远端夹头234仍夹持瓣叶6,如图20所示。The sixth step; by rotating the
第七步:将穿刺针25、第一推送件273及限位件275向近端移动至脱离由近端夹头232与远端夹头234夹持的瓣叶6,然后再次控制驱动杆236向远端移动以带动远端夹头234相对近端夹头232打开,再使得人工腱索10从远端夹头234的通道238中脱出,撤除人工腱索植入装置20;此时,人工腱索10穿过瓣叶6,且远端通过锚钉271固定在乳头肌或者心室壁上,近端延伸至患者体外,如图21所示。Step 7: Move the
第八步;如图22所示,将垫片30及第二推送件40分别套设于人工腱索10上,通过第二推送件40将垫片30沿人工腱索10推送至左心房内,直至垫片10接触瓣叶6。The eighth step; as shown in Figure 22, the
第九步:如图23所示,通过锁结装置50将人工腱索10锁结固定于垫片30远离瓣叶6的一侧,并裁断垫片30近侧的多余人工腱索10,完成人工腱索10植入。可以理解的是,在此步骤中,也可以通过打结的方式锁结固定人工腱索10。The ninth step: as shown in FIG. 23, the
本发明提供的介入式人工腱索植入系统9,在穿刺针25内活动穿设锚定组件27,在远端夹头234上设置沿轴向贯通且穿通远端夹头234侧壁的通道238供穿刺针25活动穿入,通过夹持组件23夹持瓣叶,通过穿刺针25及其内的锚定组件27穿刺瓣叶,随后通过第一推送件273将锚钉271推出穿刺针25及远端夹头234直至锚钉271锚入心室壁或乳头肌,使得与穿刺针25连接的人工腱索10借助锚钉271锚定于心室壁或乳头肌。与现有技术相比,省略了在远端夹头内设置套筒,穿刺针25仅需穿刺瓣叶,无需穿刺针和套筒配合并形成连接的操作,简化了器械结构及操作过程;此外,使用同一套器械即可完成瓣叶穿刺和锚钉固定,操作步骤得以减少,有利于简化手术过程及节省手术时间。In the interventional artificial chordae
可以理解的是,本发明的介入式人工腱索植入系统9还可以适用于以下场景,例如,经颈静脉-上腔静脉-右心房-房间隔-左心房-二尖瓣的路径进行经导管介入式二尖瓣的人工腱索植入、经左心房-二尖瓣的路径进行经心房介入式二尖瓣的人工腱索植入,再例如,经股静脉-下腔静脉-右心房-三尖瓣的路径进行经导管介入式三尖瓣的人工腱索植入、经颈静脉-上腔静脉-右心房-三尖瓣的路径进行经导管介入式三尖瓣的人工腱索植入、经右心房-三尖瓣的路径进行经心房介入式三尖瓣的人工腱索植入,此处不做赘述,经导管介入方式比经心房方式对人体的损伤更小。It can be understood that the interventional artificial chordae
请一并参阅图24至图26,本发明第二实施例提供的介入式人工腱索植入系统与第一实施例提供的介入式人工腱索植入系统9的结构相似,不同之处在于:第二实施例中,锚钉271为自膨式锚钉,第一推送件273的远端抵接锚钉271的近端,第一推送件273可直接将锚钉271抵推出穿刺针25的远端,锚钉271自动膨胀以锚入心室壁或乳头肌。与第一实施例相比,第二实施例中,第一推送件273与锚钉271直接抵接,不需要设置连接部,从而可以省去限位件275,有利于简化介入式人工腱索植入系统的整体结构,节省成本。Please refer to FIG. 24 to FIG. 26 together. The structure of the interventional artificial chord implantation system provided by the second embodiment of the present invention is similar to that of the interventional artificial
具体的,如图24至图26所示,第二实施例中,锚钉271包括钉体2717及连接于钉体2717上的至少一个锚片2719。优选的,锚片2719的数量设置为多个,有利于增加锚钉271的锚定力。其中,钉体2717呈环状结构,多个锚片2719沿钉体2717的周向间隔设置于钉体2717的近端,每一锚片2719的近端(即远离钉体2717的一端)为尖锐端。进一步优选的,多个锚片2719沿钉体2717的周向均匀间隔设置,在多个锚片2719锚入心室壁或乳头肌的过程中,心室壁或乳头肌通过多个锚片2719作用于锚钉271的作用力比较均衡,有利于提高锚钉271的锚入稳定性。Specifically, as shown in FIGS. 24 to 26 , in the second embodiment, the
需要说明的是,第二实施例中,锚钉271中至少锚片2719是由形状记忆材料经热定型处理制成,优选镍钛合金,锚片2719在自由状态下呈弯曲状,当锚片2719受外力作用时可发生弹性变形而变成平直状。具体的,请一并参阅图24及图25,锚钉271被第一推送件273推出穿刺针25的远端之前,多个锚片2719受穿刺针25的限制处于相对合拢状态;请一并参阅图24及图26,锚钉271被第一推送件273推出穿刺针25的远端之后,多个锚片2719处于展开状态,每一锚片2719的尖锐端朝向钉体2717同时朝外弯曲,以锚入心室壁或乳头肌。It should be noted that, in the second embodiment, at least the
在使用第二实施例提供的介入式人工腱索植入系统时,穿刺针25及其内部的锚钉271穿过瓣叶后,穿刺针25继续向远端推进,直至穿刺针25穿入心室壁或乳头肌中,通过向远端推送第一推送件273或者向近端后撤穿刺针25,以使自膨式锚钉271伸出穿刺针25的远端,锚片2719展开从而锚入心室壁或乳头肌中。When the interventional artificial chordae tendineae implantation system provided in the second embodiment is used, after the
可选地,在其他实施例中,钉体2717的远端为尖锐端,锚定组件27还包括活动穿设于穿刺针25内的中间件,锚钉271及第一推送件273活动穿设于所述中间件内。在使用该实施例提供的介入式人工腱索植入系统时,穿刺针25穿刺完瓣叶后即停止推送,然后同步推送所述中间件与第一推送件273直至所述中间件抵接心室壁或乳头肌后,停止推送所述中间件,仅推送第一推送件273,将锚钉271推出所述中间件的远端,锚钉271的钉体2717的尖锐端刺入心室壁或乳头肌,锚片2719展开并锚入心室壁或乳头肌,从而将人工腱索10锚定于心室壁或乳头肌上。Optionally, in other embodiments, the distal end of the
其中,所述中间件为中空的管体,具有一定刚性和柔顺性,所述中间件可以由生物相容性良好的金属材料或者高分子材料制成,例如镍钛或者Peek。Wherein, the middle piece is a hollow tube body with certain rigidity and flexibility, and the middle piece can be made of a metal material or a polymer material with good biocompatibility, such as nickel titanium or Peek.
此外,与第一实施例的不同之处还在于:第二实施例中,环状结构的钉体2717设有容置腔(未标示),所述容置腔固定连接一沿径向延伸的销棒2712,人工腱索10对折,且人工腱索10的对折的部位绕过销棒2712,从而实现人工腱索10与锚钉271的连接。第二实施例中,对折的人工腱索10通过锚钉271锚定于乳头肌或者心肌后,等同于两根人工腱索10的植入。In addition, the difference from the first embodiment is that in the second embodiment, the
以上是本发明实施例的实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明实施例原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也视为本发明的保护范围。The above are the implementations of the embodiments of the present invention. It should be pointed out that for those of ordinary skill in the art, without departing from the principles of the embodiments of the present invention, several improvements and modifications can also be made. These improvements and modifications are also It is regarded as the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011640133.7A CN114681152B (en) | 2020-12-31 | 2020-12-31 | Interventional artificial chord implantation system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011640133.7A CN114681152B (en) | 2020-12-31 | 2020-12-31 | Interventional artificial chord implantation system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114681152A true CN114681152A (en) | 2022-07-01 |
| CN114681152B CN114681152B (en) | 2025-07-15 |
Family
ID=82135501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011640133.7A Active CN114681152B (en) | 2020-12-31 | 2020-12-31 | Interventional artificial chord implantation system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114681152B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012040865A1 (en) * | 2010-10-01 | 2012-04-05 | Alberto Weber | Medical apparatus and method for heart valve repair |
| CN107569301A (en) * | 2017-07-31 | 2018-01-12 | 天之纬医疗科技(上海)有限公司 | Artificial cords and its artificial cords implant system |
| US20190183648A1 (en) * | 2017-12-20 | 2019-06-20 | W. L. Gore & Associates, Inc. | Artificial chordae tendineae repair devices and delivery thereof |
| CN211934428U (en) * | 2019-12-27 | 2020-11-17 | 杭州德晋医疗科技有限公司 | Transcatheter anchor implantation device and transcatheter anchor implantation system |
-
2020
- 2020-12-31 CN CN202011640133.7A patent/CN114681152B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012040865A1 (en) * | 2010-10-01 | 2012-04-05 | Alberto Weber | Medical apparatus and method for heart valve repair |
| CN107569301A (en) * | 2017-07-31 | 2018-01-12 | 天之纬医疗科技(上海)有限公司 | Artificial cords and its artificial cords implant system |
| US20190183648A1 (en) * | 2017-12-20 | 2019-06-20 | W. L. Gore & Associates, Inc. | Artificial chordae tendineae repair devices and delivery thereof |
| CN211934428U (en) * | 2019-12-27 | 2020-11-17 | 杭州德晋医疗科技有限公司 | Transcatheter anchor implantation device and transcatheter anchor implantation system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114681152B (en) | 2025-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11571307B2 (en) | Methods, devices, and systems for percutaneously anchoring annuloplasty rings | |
| US20250032255A1 (en) | Percutaneous annuloplasty system with anterior-posterior adjustment | |
| CN110313947B (en) | Heart valve repair system | |
| EP3441045B1 (en) | Apparatus to draw first and second portions of tissue toward each other | |
| JP4611991B2 (en) | Fastening device, device and method for engaging tissue | |
| JP2022534021A (en) | Delivery system for heart valve device | |
| RU2019121972A (en) | Method and device for transvascular implantation of tendon neochord | |
| US20100268253A1 (en) | System and method for closure of an internal opening in tissue, such as a trans-apical access opening | |
| US20190343626A1 (en) | Low profile tissue anchor for minimally invasive heart valve repair | |
| CN108289662A (en) | Medical devices and methods for heart valve repair | |
| WO2019217638A9 (en) | Systems and methods for transcatheter heart valve repair | |
| US20240023951A1 (en) | Device for heart repair | |
| WO2019105073A1 (en) | Dual-side artificial chordae tendineae implantation system | |
| CN114681132B (en) | Heart valve repair device | |
| CN119055407B (en) | Cardiac anchors and cardiac anchoring systems | |
| CN114681152A (en) | Interventional artificial chordae implantation system | |
| CN215778921U (en) | Interventional artificial chordae implantation system | |
| CN212490255U (en) | Edge-to-edge repair device and edge-to-edge repair system | |
| US20240325149A1 (en) | Method and System for Transcatheter Chordae Tendineae Repair | |
| CN113017921B (en) | Transcatheter suture implantation device and transcatheter tendon chord implantation system | |
| CN113274167B (en) | Edge-to-edge repair device and edge-to-edge repair system | |
| JP2025507913A (en) | Soft Tissue Anchor System for Cardiac Repair | |
| CN120093483A (en) | Valve ring retraction device | |
| CN119700373A (en) | Atrioventricular valve area reduction system | |
| WO2021129006A1 (en) | Transcatheter suture line implantation device and transcatheter chordae tendineae implantation system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |